Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!



About the author: 

If at first tamoxifen doesn't succeed, try, try Megace

If at first tamoxifen doesn't succeed, try, try Megace. That seems to be the policy of many oncologists when they're treating breast cancer.

It may be fashion, it may be because the oncologists see tamoxifen as being a more effective drug, but whatever the reason, Megace seems destined to be always the bridesmaid and never the bride.

In one sense, this collective decision is unfortunate because Megace does not boast anything like the impressive array of side effects and adverse reactions that tamoxifen can muster.

Regular dosage for treating breast cancer is 160 mg a day, and no serious side effects have been detected, even at 1evels of 1600 mg a day.

But if a drug is to do good, it must also have the potential to do harm, and Megace is no exception.

Pregnant women, in particular, are warned not to take the drug because of the harm it can cause to the fetus. Similarly, breastfeeding mothers should also stop the treatment.

Adverse reactions include weight gain one of the most common side effects among patients although this seems to be attributable more to an increased appetite than fluid retention. Thrombosis is a serious concern, especially among those who may be susceptible, although it is a rare reaction.

Other reactions include nausea and vomiting, edema, bleeding, tumour flare, hyperglycemia, alopecia, hypertension, carpal tunnel syndrome and rash.

Like so many drugs, Megace seems to have a paradoxical effect when tested on animals. Female dogs developed benign and malignant tumours of the breast after being given the drug for seven years, although these results were not replicated when tests were carried out on rats and monkeys.

Arthritis: relief from fatty acids

Beta-carotene: now the good news

You may also be interested in...

Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved